Volunteer Login Study Team Login

Print

Lay Description

This randomized phase III trial is studying different combination chemotherapy regimens and comparing how well they work in treating patients with newly diagnosed acute lymphoblastic leukemia. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells.

Category

  • Behaviors and Mental Disorders
IRB Number
20050285HU
NCT Number
ct.gov registration not required
Open to Enrollment
Yes

Eligibility

Eligible Ages
1 Year - 9 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

Exclusion Criteria

Study Design

Study Contact


Regulatory Point of Contact
Janice Marceaux
janice.marceaux@va.gov

Regulatory Point of Contact
Janice Marceaux
janice23@uab.edu

Principal Investigator
Janice Marceaux